Metabolomic and lipidomic study of the protective effect of Chaihuang-Yishen formula on rats with diabetic nephropathy

Journal of Ethnopharmacology

Volumn 166, Issue , 2015, Pages 31-41

  Zhao, Tie ^a   Zhang, Haojun ^a   Zhang, Xianglin ^a   Zhao, Tingting ^a   Lan, Hui Yao ^b   Liang, Qionglin ^c   Luo, Guoan ^c   Li, Ping ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Tsinghua University   (China)

Author keywords

Chaihuang Yishenformula; Diabetic nephropathy; Lipidomics; Metabolomics; UPLCTOF MS

Indexed keywords

AMINO ACID; CHAIHUANG YISHEN FORMULA; DOCOSAPENTAENOIC ACID; FOSINOPRIL; GLUCOSE; GLUCURONIDE; HERBACEOUS AGENT; HIPPURIC ACID; HYDROXYACID; PHENETHYL ALCOHOL; PHOSPHOLIPID; PROTECTIVE AGENT; PYRIDOXIC ACID; SPHINGOMYELIN; TAURINE; UNCLASSIFIED DRUG; UREMIC TOXIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GAS CHROMATOGRAPHY; KIDNEY CORTEX; LIPIDOMICS; MALE; METABOLOMICS; NONHUMAN; RAT; RENAL PROTECTION; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UNINEPHRECTOMY; ANIMAL; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; METABOLISM; METABOLOME; PROCEDURES; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; KIDNEY CORTEX; MALE; METABOLOME; METABOLOMICS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84925671154     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.02.019     Document Type: Article

References (34)

1. H. Abe, T. Matsubara, H. Arai, and T. Doi Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker Histol. Histopathol. 26 2011 531 541
2. Y.Q. Bao, T. Zhao, X.Y. Wang, Y.P. Qiu, M.M. Su, and W. Jia Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers J. Proteome Res. 8 2009 1623 1630
3. C.D. Cohen, M.T. Lindenmeyer, F. Eichinger, A. Hahn, M. Seifert, A.G. Moll, H. Schmid, E. Kiss, E. Gröne, and H.J. Gröne Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis PLoS One 3 2008 e2937 (e2937)
4. M. Dunlop Aldose reductase and the role of the polyol pathway in diabetic nephropathy Kidney Int. 58 2000 3 12
5. K. Geoffroy, L. Troncy, N. Wiernsperger, M. Lagarde, and S.E. Bawab Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels FEBS Lett. 579 2005 1249 1254
6. L.D. Han, J.F. Xia, Q.L. Liang, Y.M. Wang, P. Hu, and G.A. Luo Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy Anal. Chim. Acta. 689 2011 85 91
7. J.M. Haus, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, R.A. Defronzo, and J.P. kIRWAN Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 2009 337 343
8. C. Heilig, L. Concepcion, B. Riser, S. Freytag, M. Zhu, and P. Cortes Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype J. Clin. Investig. 96 1995 1802 1814
9. C. Heilig, Y. Liu, R. England, S. Freytag, J. Gilbert, K. Heilig, M. Zhu, L. Concepcion, and F. Brosius D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy Diabetes 46 1997 1030 1039
10. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, Y. Ogawa, H. Imamaki, T. Kawanishi, and A. Ishii Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by toll-like receptor 4 in mice Diabetologia 55 2012 2256 2266
11. D.H. Kwak, Y.I. Rho, O.D. Kwon, S.H. Ahan, J.H. Song, Y.K. Choo, S.J. Kim, B.K. Choi, and K.Y. Jung Decreases of ganglioside GM3 in streptozotocin-induced diabetic glomeruli of rats Life Sci. 72 2003 1997 2006
12. R. Laaksonen, M. Katajamaa, H. Paiva, M. Sysi-Aho, L. Saarinen, P. Junni, D. Lutjohann, J. Smet, R. Van Coster, T. Seppanen-Laakso, T. Lehtimaki, J. Soini, and M. Oresic A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle PLoS One 1 2006 e97
13. G. Lemieux, B. Moulin, J. Davignon, and Y. Haung The lipid content of the diabetic kidney of the rat Can. J. Physiol. Pharmacol. 62 1984 1274 1278
14. H.K. Li, Y. Ni, M.M. Su, Y.P. Qiu, M.M. Zhou, M.F. Qiu, A.H. Zhao, L.P. Zhao, and W. Jia Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats J. Proteome Res. 6 2007 1364 1370
15. P. Li Professor Zhensheng Shi' clinical experience in treating chronic nephritis Zhongguo Zhong xi yi jie he shen bing za zhi=Chin. J. Integr. Tradit. West. Nephrol. 6 2005 129 131
16. P. Li, J. Yan, Y. Sun, F.J. Burczynski, and Y.W. Gong Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins Nephrology 12 2007 466 473
17. K.C. Linden, C.L. DeHaan, Y. Zhang, S. Glowacka, A.J. Cox, D.J. Kelly, and S. Rogers Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy Am. J. Physiol. Ren. Physiol. 290 2006 F205
18. G.Y. Liu, F. Han, Y. Yang, Y. Xie, H. Jiang, Y.Y. Mao, H.P. Wang, M.M. Wang, R.J. Chen, and J. Yang Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin Nephrol. Dial. Transplant. 26 2011 1493 1502
19. S. Mohan, K. Kalia, and J. Mannari Diabetic nephropathy and associated risk factors for renal deterioration Int. J. Diabetes Dev. Ctry. 32 2012 52 59
20. E.D. Schleicher, and C. Weigert Role of the hexosamine biosynthetic pathway in diabetic nephropathy Kidney Int. 58 2000 13 18
21. A.G. Smith, and J.R. Singleton Obesity and hyperlipidemia are risk factors for early diabetic neuropathy J. Diabetes Complicat. 27 2013 436 442
22. Y.M. Sun, Y. Su, J. Li, and L.F. Wang Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy Biochem. Biophys. Res. Commun. 433 2013 359 361
23. Y. Tsutsumi, T. Deguchi, M. Takano, A. Takadate, W.E. Lindup, and M. Otagiri Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat J. Pharmacol. Exp. Ther. 303 2002 880 887
24. B. Wang, S. Zhao, J. Guo, O. ZL, L. Pan, P. Li, L. Jia, J. Yan, G. Fu, and K.M. Li Effects of Chailing-Yishen formula on rats with chronic nephropathy induced by puromycin aminonucleoside Zhongguo Xin yao za zhi=Chin. J. New Drugs 15 2006 1739 1743
25. W.R. Wikoff, A.T. Anfora, J. Liu, P.G. Schultz, S.A. Lesley, E.C. Peters, and G. Siuzdak Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc. Natl. Acad. Sci. 106 2009 3698 3703
26. W.R. Wikoff, J.A. Gangoiti, B.A. Barshop, and G. Siuzdak Metabolomics identifies perturbations in human disorders of propionate metabolism Clin. Chem. 53 2007 2169 (2076)
27. J.F. Xia, Q.L. Liang, P. Hu, Y.M. Wang, P. Li, and G.A. Luo Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients Clin. Biochem. 42 2009 215 220
28. W.D. Xie, Y.N. Zhao, and Y.O. Zhang Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus Evid. Based Complement. Altern. Med. 2011 2011 1 13
29. H.B. Xu, R.H. Jiang, X.Z. Chen, and L. Li Chinese herbal medicine in treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis J. Ethnopharmacol. 143 2012 701 708
30. H. Zhang, T. Zhao, Y. Gong, X. Dong, W. Zhang, S. Sun, H. Wang, Y. Gu, X. Lu, and M. Yan Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics J. Ethnopharmacol. 151 2014 556 564
31. J. Zhang, L. Yan, W. Chen, L. Lin, X. Song, X. Yan, W. Hang, and B. Huang Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system Anal. Chim. Acta 650 2009 16 22
32. T. Zhao, H.J. Zhang, T.T. Yin, X.G. Lu, T.T. Zhao, and P. Li Lipidomic Study of Protective Effect of Chaihuang Yishen Graunules on Rats with Diabetic Nephropathy Chin. J. Exp. Tradit. Med. Formulae 18 2012 155 162
33. T. Zhao, H.J. Zhang, X.L. Zhang, J. Lu, T.T. Yin, Q.L. Liang, Y.M. Wang, G.A. Luo, H.Y. Lan, and P. Li Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease J. Pharm. Biomed. Anal. 60 2012 32 43
34. T.T. Zhao, H.J. Zhang, X.G. Lu, X.R. Huang, W.K. Zhang, H. Wang, H.Y. Lan, and P. Li Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling PloS one 9 2014 e90807